David Zidar, MD

Showing    of 2 results

Clinical Trial at UH Seeks to Improve Outcomes for TAVR Patients

Two anti-platelet drugs studied for their effect on platelet function and immune activation post-procedure Innovations in Cardiovascular Medicine & Surgery - Fall 2018  David A. Zidar, MD, PhD Transcatheter aortic valve replacement (TAVR) has...

Read More

Making the Case for CT CORONARY CALCIUM SCORING

Innovative, no-cost program increases access to vital test Harrington Heart & Vascular Institute Innovations - Spring 2016, updated January 2017 David A. Zidar, MD, PHD Robert C Gilkeson, MD Preventive cardiologists continue to refine their risk...

Read More

Results are loading...